Considering the above information, in this study, the possible imbalance between VWF and ADAMTS13 in HCC was investigated using bioinformatics databases and microarray data, and the potential of the spectacular imbalance between VWF and ADAMTS13 in HCC as a therapeutic agent was evaluated. This evidence concerns the gene VWF and hepatocellular carcinoma.